refractory anemia
Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels.
Effect of treatment with amifostine used as a single agent in patients with <span class="disease" id="10870480-0-76-93">refractory anemia</span> on clinical outcome and serum <span class="gene" id="10870480-0-124-151">tumor necrosis factor alpha</span> levels.